Green tea catechins: A fresh flavor to anticancer therapy

Apoptosis

Volumn 19, Issue 1, 2014, Pages 1-18

  Yu, Yang ^a   Deng, Yuan ^a   Lu, Bang Min ^a   Liu, Yong Xi ^a   Li, Jian ^b   Bao, Jin Ku ^a  

^a SICHUAN UNIVERSITY   (China)

^b OHIO UNIVERSITY   (United States)

Author keywords

Anticancer mechanisms; EGCG; Green tea catechins; Synergetic effects; Therapeutic agents

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; CATECHIN DERIVATIVE; CATECHOL DERIVATIVE; CYTOTOXIC AGENT; EPICATECHIN GALLATE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GLUTATHIONE TRANSFERASE; GLYCOGEN SYNTHASE KINASE 3; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXALIPLATIN; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL DERIVATIVE; POLYPHENON E; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 8; SOMATOMEDIN C; SULINDAC; TAMOXIFEN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER STEM CELL; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXICITY; DETOXIFICATION; DNA DAMAGE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG INFORMATION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVITY; FLAVOR; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TEA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMELLIA SINENSIS; CATECHIN; HUMANS; NEOPLASMS; PLANT EXTRACTS;

EID: 84892754530     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0908-5     Document Type: Review

References (144)

1. Sang S, Lambert JD, Ho C-T, Yang CS (2011) The chemistry and biotransformation of tea constituents. Pharmacol Res 64:87-99
2. Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429-439
3. Feng WY (2006) Metabolism of green tea catechins: an overview. Curr Drug Metab 7:755-809
4. Cao Y, Cao R (1999) Angiogenesis inhibited by drinking tea. Nature 398:381
5. Singh BN, Shankar S, Srivastava RK (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82:1807-1821
6. Yang CS, Lambert JD, Ju J, Lu G, Sang S (2007) Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharm 224:265-273
7. Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci 43(1):89-143
8. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H (1999) Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 59:44-47
9. Hu B, Wang L, Zhou B, Zhang X, Sun Y, Ye H et al (2009) Efficient procedure for isolating methylated catechins from green tea and effective simultaneous analysis of ten catechins, three purine alkaloids, and gallic acid in tea by high-performance liquid chromatography with diode array detection. J Chromatogr A 1216:3223-3231
10. Saha A, Kuzuhara T, Echigo N, Suganuma M, Fujiki H (2010) New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin. Cancer Prev Res 3:953-962
11. Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W et al (2001) EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. BRIT J Cancer 84:844
12. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB (2005) (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11:2735-2746
13. Hirose M, Mizoguchi Y, Yaono M, Tanaka H, Yamaguchi T, Shirai T (1997) Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7, 12-dimethylbenz (\i[a\/i[) anthracene. Cancer Lett 112:141-147
14. Yan Y, Cook J, McQuillan J, Zhang G, Hitzman CJ, Wang Y et al (2007) Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice. Neoplasia 9:401
15. Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM et al (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin Cancer Res 11:4627-4633
16. Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP (2011) EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem 53:155
17. Johnson J, Bailey H, Mukhtar H (2010) Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 17:3-13
18. Myung SK, Bae WK, Oh SM, Kim Y, Ju W, Sung J et al (2009) Green tea consumption and risk of stomach cancer: a metaanalysis of epidemiologic studies. Int J Cancer 124:670-677
19. Zheng P, H-m Zheng, X-m Deng (2012) Green tea consumption and risk of esophageal cancer: a meta-Analysis of epidemiologic studies. BMC gastroenterol 12:165
20. Chen Z, Chen Q, Xia H, Lin J (2011) Green tea drinking habits and esophageal cancer in southern China: a case-control study. Asian Pac J Cancer Prev 12:229-233
21. Yuan J-M, Koh W-P, Sun C-L, Lee H-P, Mimi CY (2005) Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 26:1389-1394
22. Lin IH, Ho ML, Chen HY, Lee HS, Huang CC, Chu YH et al (2012) Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk. PLoS ONE 7:e30951
23. Kumar N, Shibata D, Helm J, Coppola D, Malafa M (2007) Green tea polyphenols in the prevention of colon cancer. Front Biosci 12:302-309
24. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA et al (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 9:3312-3319
25. Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK et al (2009) Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res 2:931-941
26. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P et al (2003) A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97:1442-1446
27. Luo H, Tang L, Tang M, Billam M, Huang T, Yu J et al (2006) Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 27:262-268
28. Zhang T, Zhang J, Derreumaux P, Mu Y (2013) Molecular mechanism of the inhibition of EGCG on the Alzheimer's Ab1-42 dimer. J Phys Chem B 117:3993-4002
29. Chen D, Pamu S, Cui Q, Chan TH, Dou QP (2012) Novel epigallocatechin gallate (EGCG) analogs activate AMP-Activated protein kinase pathway and target cancer stem cells. Bioorgan Med Chem 20:3031-3037
30. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, Gescher AJ (2007) Dietary polyphenolic phytochemicals-Promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120:451-458
31. Yang CS, Wang X (2010) Green tea and cancer prevention. Nutr Cancer 62:931-937
32. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66:2500-2505
33. Surh Y-J (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768-780
34. Hastak K,Gupta S,Ahmad N,AgarwalMK,AgarwalML,Mukhtar H (2003) Role of p53 and NF-jB in epigallocatechin-3-gallateinduced apoptosis of LNCaP cells. Oncogene 22:4851-4859
35. Lambert JD, Elias RJ (2010) The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501:65-72
36. Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S-3284S
37. Inami S, Takano M, Yamamoto M, Murakami D, Tajika K, Yodogawa K et al (2007) Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Int Heart J 48:725-732
38. Yamamoto Y, Gaynor RB (2001) Therapeutic potential of inhibition of the NF-jB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135-142
39. Dong Z, W-y Ma, Huang C, Yang CS (1997) Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 57:4414-4419
40. Karin M, Cao Y, Greten FR, LiZW(2002) NF-jB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310
41. Khan SG, Katiyar SK, Agarwal R, Mukhtar H (1992) Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res 52:4050-4052
42. Reuland DJ, Khademi S, Castle CJ, Irwin DC, McCord JM, Miller BF et al (2013) Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Free Radic Bio Med 56:102-111
43. Na H-K, Surh Y-J (2008) Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol 46:1271-1278
44. Blagosklonny M (2005) Carcinogenesis, cancer therapy and chemoprevention. Cell Death Differ 12:592-602
45. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK (2007) Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245:232
46. Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J et al (2005) Inhibition of intestinal tumorigenesis in Apcmin/? mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65:10623-10631
47. Huh SW, Bae SM, Kim YW, Lee JM, Namkoong SE, Lee IP et al (2004) Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol 94:760
48. Stillman B (1996) Cell cycle control of DNA replication. Science 274:1659-1663
49. Graña X, Reddy EP (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211
50. Nigg EA (1995) Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. BioEssays 17:471-480
51. Massague J (2004) G1 cell-cycle control and cancer. Nature 432:298-306
52. Kim CH, Moon SK (2005) Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-Alpha-induced vascular smooth muscle cells. Arch Biochem Biophys 435:264-272
53. Peng G, Wargovich MJ, Dixon DA (2006) Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells. Cancer Lett 238:260-270
54. Tan X, Hu D, Li S, Han Y, Zhang Y, Zhou D (2000) Differences of four catechins in cell cycle arrest and induction of apoptosis in LoVo cells. Cancer Lett 158:1-6
55. Han DW, Lee MH, Kim HH, Hyon SH, Park JC (2011) Epigallocatechin-3- gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-jB in human dermal fibroblasts. Acta Pharmacol Sin 32:637-646
56. Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11-22
57. Agarwal R (2000) Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 60:1051-1059
58. Wu D, Guo Z, Ren Z, Guo W, Meydani SN (2009) Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling. Free Radic Bio Med 47:636-643
59. Lin SC, Li WC, Shih JW, Hong KF, Pan YR, Lin JJ (2006) The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells. Cancer Lett 236:80-88
60. Baatout S, Derradji H, Jacquet P, Mergeay M (2005) Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma. Int J Mol Med 15:337-352
61. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397-1421
62. Khan N, Mukhtar H (2008) Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269:269-280
63. Sarkar FH, Li Y, Wang Z, Kong D (2009) Cellular signaling perturbation by natural products. Cell Signal 21:1541-1547
64. Lambert JD, Yang CS (2003) Mechanisms of cancer prevention by tea constituents. J Nutr 133:3262S-3267S
65. Miner JN, Yamamoto KR (1992) The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Gene Dev 6:2491-2501
66. Yang CS, Lambert JD, Hou Z, Ju J, Lu G, Hao X (2006) Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog 45:431-435
67. Tachibana H, Koga K, Fujimura Y, Yamada K (2004) A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11:380
68. Samani AA, Yakar S, LeRoith D, Brodt P (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47
69. Yang CS, Sang S, Lambert JD, Hou Z, Ju J, Lu G (2006) Possible mechanisms of the cancer-preventive activities of green tea. Mol Nutr Food Res 50:170-175
70. Chung JY, Huang C, Meng X, Dong Z, Yang CS (1999) Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells structure-Activity relationship and mechanisms involved. Cancer Res 59:4610-4617
71. Smith DM, Wang Z, Kazi A, Li L-H, Chan T-H, Dou QP (2002) Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol Med 8:382-392
72. Gusman J, Malonne H, Atassi G (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22:1111-1117
73. Gosslau A, Chen KY (2004) Nutraceuticals, apoptosis, and disease prevention. Nutrition 20:95-102
74. Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS et al (2002) Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. P Natl Acad Sci USA 99:12455-12460
75. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE (2004) VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 104:788-794
76. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776
77. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Bi 15:269-290
78. Salvesen GS, Dixit VM (1999) Caspase activation: the inducedproximity model. P Natl Acad Sci USA 96:10964-10967
79. Qin J, Xie LP, Zheng XY, Wang YB, Bai Y, Shen HF et al (2007) A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Bioph Res Co 354:852-857
80. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H (2004) Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23:2507-2522
81. Brusselmans K, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV (2003) Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int J Cancer 106:856-862
82. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S et al (2008) Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27:2055-2063
83. Roy AM, Baliga MS, Katiyar SK (2005) Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther 4:81-90
84. Shankar S, Chen Q, Srivastava RK (2008) Inhibition of PI3K/ AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J Mol Signal 3:7
85. Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7:79-94
86. Jung YD, Ellis LM (2001) Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol 82:309-316
87. Yamakawa S, Asai T, Uchida T, Matsukawa M, Akizawa T, Oku N (2004) (-)-Epigallocatechin gallate inhibits membranetype 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 210:47-55
88. Khan N, Mukhtar H (2010) Cancer and metastasis: prevention and treatment by green tea. Cancer Metast Rev 29:435-445
89. Garbisa S, Biggin S, Cavallarin N, Sartor L, Benelli R, Albini A (1999) Tumor invasion: molecular shears blunted by green tea. Nat Med 5:1216
90. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174
91. Bigelow R, Cardelli J (2006) The green tea catechins,(-)- epigallocatechin-3-gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 25:1922-1930
92. Suzuki Y, Isemura M (2001) Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer letters 173:15-20
93. Punathil T, Tollefsbol TO, Katiyar SK (2008) EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem Biophys Res Co 375:162-167
94. Tang FY, Chiang EP, Shih CJ (2007) Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. J Nutr Biochem 18:391-399
95. Fassina G, Vene R, Morini M, Minghelli S, Benelli R, Noonan DM et al (2004) Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res 10:4865-4873
96. Lamy S, Gingras D, Beliveau R (2002) Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 62:381-385
97. Kondo T, Ohta T, Igura K, Hara Y, Kaji K (2002) Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett 180:139-144
98. Liu L, Lai CQ, Nie L, Ordovas J, Band M, Moser L et al (2008) The modulation of endothelial cell gene expression by green tea polyphenol-EGCG. Mol Nutr Food Res 52:1182-1192
99. Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z et al (2011) (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. WJG 17:2315-2325
100. Tang FY, Meydani M (2001) Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr Cancer 41:119-125
101. Kim YS, Farrar W, Colburn NH, Milner JA (2012) Cancer stem cells: potential target for bioactive food components. J Nutr Biochem 23:691-698
102. Li Y, Wicha MS, Schwartz SJ, Sun D (2011) Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J Nutr Biochem 22:799-806
103. Tang S-N, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK (2010) The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal 5:14
104. Curtin JC, Lorenzi MV (2010) Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 1:552
105. Bode AM, Dong Z (2009) Epigallocatechin 3-gallate and green tea catechins: united they work, divided they fail. Cancer Prev Res 2:514-517
106. Suganuma M, Saha A, Fujiki H (2011) New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102:317-323
107. Scandlyn M, Stuart E, Somers-Edgar T, Menzies A, Rosengren R (2008) A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. BRIT J Cancer 99:1056-1063
108. Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM et al (2006) The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27:2424-2433
109. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT et al (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56:2556-2560
110. Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM (2002) Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122:641-645
111. Fujiki H, Suganuma M, Kurusu M, Okabe S, Imayoshi Y, Taniguchi S et al (2003) New TNF-A releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mutat Res-Fund Mol M 523:119-125
112. Kim SH, Hwang CI, Juhnn YS, Lee JH, Park WY, Song YS (2007) GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis 28:223-231
113. Sharafkhaneh A, Velamuri S, Moghaddam SJ, Badmaev V, Dickey B, Kurie J. (2008) Natural Agents for Chemoprevention of Lung Cancer. Lung Cancer:441
114. Suganuma M, Kurusu M, Suzuki K, Tasaki E, Fujiki H (2006) Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int J Cancer 119:33-40
115. Somers-Edgar TJ, Scandlyn MJ, Stuart EC, Le Nedelec MJ, Valentine SP, Rosengren RJ (2008) The combination of epigallocatechin gallate and curcumin suppresses ERa-breast cancer cell growth in vitro and in vivo. Int J Cancer 122:1966-1971
116. Khafif A, Schantz SP, Chou TC, Edelstein D, Sacks PG (1998) Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 19:419-424
117. Amin AR, Khuri FR, Shin DM (2009) Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-jB. Cancer Prev Res 2:538-545
118. Hou Z, Sang S, You H, Lee MJ, Hong J, Chin KV et al (2005) Mechanism of action of (-)-epigallocatechin-3-gallate: autooxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 65:8049-8056
119. Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM et al (2007) Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett 247:115-121
120. Chen H, Landen CN, Li Y, Alvarez RD, Tollefsbol TO (2013) Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation. Exp Cell Res 319:697-706
121. Luo T, Wang J, Yin Y, Hua H, Jing J, Sun X et al (2010) (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res. doi:10.1186/bcr2473
122. Kweon MH, Adhami VM, Lee JS, Mukhtar H (2006) Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem 281:33761-33772
123. Levites Y, Amit T, Youdim MBH, Mandel S (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277:30574-30580
124. Urusova DV, Shim JH, Kim DJ, Jung SK, Zykova TA, Carper A et al (2011) Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res 4:1366-1377
125. Niedzwiecki A, Roomi MW, Kalinovsky T, Rath M (2010) Micronutrient synergy-A new tool in effective control of metastasis and other key mechanisms of cancer. Cancer Metast Rev 29:529-542
126. Balasubramanian S, Eckert RL (2007) Keratinocyte proliferation, differentiation, and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharm 224:214-219
127. Manna S, Banerjee S, Mukherjee S, Das S, Panda CK (2006) Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression. Apoptosis 11:2267-2276
128. Katiyar S, Elmets CA, Katiyar SK (2007) Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem 18:287-296
129. Suganuma M, Sueoka E, Sueoka N, Okabe S, Fujiki H (2000) Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-A expression. Biofactors 13:67-72
130. Ohishi T, Kishimoto Y, Miura N, Shiota G, Kohri T, Hara Y et al (2002) Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett 177:49-56
131. Boreddy SR, Srivastava SK (2012) Pancreatic cancer chemoprevention by phytochemicals. Cancer Lett 334:86-94
132. Ha J, Zhao L, Zhao Q, Yao J, Zhu BB, Lu N et al (2012) Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. Biochem Cell Biol 90:521-531
133. Sadzuka Y, Sugiyama T, Hirota S (1998) Modulation of cancer chemotherapy by green tea. Clin Cancer Res 4:153-156
134. Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S et al (2012) Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Oncol Rep 28:1799-1807
135. Liang Y-C, Lin-Shiau S-Y, Chen C-F, Lin J-K (1997) Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem 67:55-65
136. Sun C-L, Yuan J-M, Koh W-P, Mimi CY (2006) Green tea, black tea and breast cancer risk: a meta-Analysis of epidemiological studies. Carcinogenesis 27:1310-1315
137. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13:49-54
138. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E (1997) Why drinking green tea could prevent cancer. Nature 387:561
139. Imai K, Suga K, Nakachi K (1997) Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26:769
140. Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C et al (2012) Phase IB randomized, double-blinded, placebocontrolled, dose escalation study of polyphenon e in women with hormone receptor-negative breast cancer. Cancer Prev Res 5:1144-1154
141. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK et al (2001) Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 19:1830-1838
142. Shanafelt TD, Call TG, Zent CS, Leis JF, LaPlant B, Bowen DA et al (2012) Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer 119(2):363-370
143. Moyers SB, Kumar NB (2004) Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev 62:204-211
144. Webb T (2000) Green tea experiments in lab, clinic yield mixed results. J Natl Cancer I 92:1038-1039